Public company Leap Therapeutics completes $58,888,888 private placement to initiate digital asset financial strategy

ChainCatcher news, biotechnology company Leap Therapeutics (NASDAQ: LPTX) announced that it has completed the previously announced private placement led by Winklevoss Capital, raising $58,888,888 in cash to initiate its digital asset financial strategy.

Winklevoss Capital will provide funding and strategic support to help Leap build and execute its digital asset financial strategy.